Pharmacy benefit managers such as CVS Caremark face mounting scrutiny
The intensifying debate over pharmacy benefits managers could ... consumers would likely pay more for their drugs at the ...
Modern Healthcare6d
Big 3 PBMs reaped $7.3B from generic specialty drug markups: FTC
Pharmacy benefit managers CVS Caremark, OptumRx and Express Scripts inflated costs for specialty generic drugs to treat diseases such as cancer and HIV to the tune of $7.3 billion over six years ...
Several Setbacks Dragged CVS Health Corp. (CVS) in Q4
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” fourth quarter ...
Zydus Lifesciences shares rise 5% on deal with US healthcare firm CVS Caremark
Zydus Lifesciences reacted sharply to the development in Tuesday's trade with the counter rising 5.23 percent to an intraday high of Rs 1,011.75 per share on the NSE.
Fierce Healthcare5d
FTC: Big 3 PBMs generated $7.3B from specialty generic drug markups
CVS Caremark, Express Scripts and OptumRx dramatically mark up specialty generic drugs to affiliated pharmacies, the Federal ...